Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | GLP1R | P43220 | 8/20 | 0.47 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.42 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | CASP2 | P42575 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10066206 | 1.00 | USP2 (0.50) | USP2CA1CA2GLP1RSIRT6 | |
| SCHEMBL21020133 | 0.97 | GLP1R (0.50) | USP2CA1CA2GLP1RSIRT6 | |
| SCHEMBL29849120 | 0.89 | USP2 (0.50) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL21020147 | 0.88 | CA1 (0.44) | USP2CA1CA2GLP1RNOD1 | |
| SCHEMBL24754575 | 0.84 | USP2 (0.51) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL14253094 | 0.82 | SIRT6 (0.59) | GLP1RSIRT6SIRT1NOD1LPAR3 | |
| SCHEMBL21019823 | 0.82 | USP2 (0.49) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL21020203 | 0.82 | USP2 (0.49) | USP2CA1CA2SIRT6SIRT1 | |
| SCHEMBL19071305 | 0.81 | GLP1R (0.49) | GLP1RSIRT6SIRT1NOD1LPAR3 | |
| SCHEMBL13336948 | 0.81 | GLP1R (0.64) | GLP1RNOD1LPAR3CASP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026088308-A1 | WATER-IN-OIL TYPE LIQUID EMULSION COSMETIC COMPOSITION | LVMH RECHERCHE (FR) | 2026-04-30 | — | — | WO | claimed |
| EP-3960246-B1 | HIGH VISCOSITY O/W EMULSION COMPOSITION CONTAINING ADENOSINE PHOSPHATE | OTSUKA PHARMA CO LTD (JP) | 2026-04-22 | — | — | EP | claimed |
| US-20250388831-A1 | GEL CANDLES | INT FLAVORS & FRAGRANCES INC (US) | 2025-12-25 | — | — | US | claimed |
| US-12491148-B2 | Adenosine phosphate-containing O/W type emulsion composition having low viscosity | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-12-09 | — | — | US | claimed |
| US-12421476-B2 | Gel candles | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2025-09-23 | — | — | US | claimed |
| US-12409118-B2 | External skin preparation | KAO CORPORATION (JP) | 2025-09-09 | — | — | US | claimed |
| EP-4608370-A1 | FACIAL CARE FORMULATIONS WITHOUT WATER | Bernier, Jean-François (CA) | 2025-09-03 | — | — | EP | claimed |
| EP-4590257-A1 | A COSMETIC COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-07-30 | — | — | EP | claimed |
| WO-2025126861-A1 | COSMETIC COMPOSITION | 株式会社 資生堂 | 2025-06-19 | — | — | WO | claimed |
| WO-2025111386-A1 | SYSTEM AND PROCESS FOR PRINTING ENCAPSULATED AND NON-ENCAPSULATED MATERIALS UTILIZING GELLING AGENTS | TEMPTIME CORPORATION (US) | 2025-05-30 | — | — | WO | claimed |
| US-20220211590-A1 | HIGH VISCOSITY O/W EMULSION COMPOSITION CONTAINING ADENOSINE PHOSPHATE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-07-07 | — | — | US | claimed |
| WO-2022138538-A1 | SOLID COSMETIC | 株式会社 資生堂 | 2022-06-30 | — | — | WO | claimed |
| US-20220202684-A1 | ADENOSINE PHOSPHATE-CONTAINING O/W TYPE EMULSION COMPOSITION HAVING LOW VISCOSITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-06-30 | — | — | US | claimed |
| CN-114469753-A | Sun-proof stick and preparation method thereof | 彭氏(惠州)实业发展有限公司 | 2022-05-13 | — | — | CN | claimed |
| WO-2022084458-A1 | PHOTOPROTECTIVE COMPOSITION | L'OREAL (FR) | 2022-04-28 | — | — | WO | claimed |
| US-20220096335-A1 | SOLID COSMETIC COMPOSITION CONTAINING AQUEOUS SPHEROIDS DISPERSED IN A SOLID CONTINUOUS ANHYDROUS PHASE | LVMH RECHERCHE (FR) | 2022-03-31 | — | — | US | claimed |
| US-20220079847-A1 | SOLID COSMETIC COMPOSITION CONTAINING ANHYDROUS SPHEROIDS DISPERSED IN A SOLID CONTINUOUS AQUEOUS PHASE | LVMH RECHERCHE (FR) | 2022-03-17 | — | — | US | claimed |
| WO-2022051163-A1 | SOLID COSMETIC | OCEAN VIEW HOLDINGS, LLC (DBA DEW MIGHTY) (US) | 2022-03-10 | — | — | WO | claimed |
| EP-3962437-A1 | EMULSIFIER-FREE SUNSCREEN GEL COMPOSITION WITH TRANSPARENT APPLICATION | L'Oréal (FR) | 2022-03-09 | — | — | EP | claimed |
| EP-3960245-A1 | ADENOSINE PHOSPHATE-CONTAINING O/W TYPE EMULSION COMPOSITION HAVING LOW VISCOSITY | Otsuka Pharmaceutical Co., Ltd. (JP) | 2022-03-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12409118-B2 | External skin preparation | CUTA, RBP4, DSG1 | USP2 211/4885CA1 4804/4885CA2 4788/4885 |
| US-20250388831-A1 | GEL CANDLES | TAS2R38, TAS2R13, TAS2R40 | USP2 1467/4885CA1 3851/4885CA2 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.